Association of Corticosteroids With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab.
JAMA Oncol
; 9(9): 1295-1298, 2023 09 01.
Article
in En
| MEDLINE
| ID: mdl-37440214
This nonrandomized controlled trial ancillary study evaluates the survival outcomes associated with corticosteroid use during nivolumab treatment for patients with metastatic renal cell carcinoma.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Antineoplastic Agents, Immunological
/
Kidney Neoplasms
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
JAMA Oncol
Year:
2023
Document type:
Article
Affiliation country: